Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 638.00 |
| Dec 31, 2025 | 528.00 |
| Sep 30, 2025 | 283.00 |
| Jun 30, 2025 | 139.00 |
| Mar 31, 2025 | -127.00 |
| Dec 31, 2024 | 155.00 |
| Sep 30, 2024 | -277.00 |
| Jun 30, 2024 | -288.00 |
| Mar 31, 2024 | -257.00 |
| Dec 31, 2023 | -647.00 |
| Sep 30, 2023 | -449.00 |
| Jun 30, 2023 | 214.00 |
| Mar 31, 2023 | -238.00 |
| Dec 31, 2022 | -321.00 |
| Sep 30, 2022 | -249.00 |
| Jun 30, 2022 | -261.00 |
| Mar 31, 2022 | 125.00 |
| Dec 31, 2021 | -35.00 |
| Sep 30, 2021 | 675.00 |
| Jun 30, 2021 | 950.00 |
| Mar 31, 2021 | 1,015.00 |
| Dec 31, 2020 | 1,053.00 |
| Sep 30, 2020 | 887.00 |
| Jun 30, 2020 | 1,228.00 |
| Mar 31, 2020 | 1,574.00 |
| Dec 31, 2019 | 2,079.00 |
| Sep 30, 2019 | 6,637.00 |
| Jun 30, 2019 | 1,794.00 |
| Mar 31, 2019 | 1,600.00 |
| Dec 31, 2018 | 829.00 |
| Sep 30, 2018 | 1,203.00 |
| Jun 30, 2018 | 1,364.00 |
| Mar 31, 2018 | 1,899.00 |
| Dec 31, 2017 | 681.00 |
| Sep 30, 2017 | 1,144.00 |
| Jun 30, 2017 | 389.00 |
| Mar 31, 2017 | 2,484.00 |
| Dec 31, 2016 | 2,322.00 |
| Sep 30, 2016 | -4,540.00 |
| Jun 30, 2016 | 2,823.00 |
| Mar 31, 2016 | -284.00 |